戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 first compartmentalized metabolic model of a parasitic worm.
2 adder of a 63-year-old male which mimicked a parasitic worm.
3 istration that uncouples the mitochondria of parasitic worms.
4 a helianthus toxin (ShK)-related peptides in parasitic worms.
5  nuocytes and their role in the expulsion of parasitic worms.
6 b), such as pathogenic bacteria, malaria and parasitic worms.
7 ew that eosinophils protect the host against parasitic worms.
8                                Helminths are parasitic worms.
9 eir traditional role in host defense against parasitic worms.
10 immune response to infection with helminthic parasitic worms.
11 cies, and was lost from most free-living and parasitic worms.
12 of infectious diseases caused by micro-scale parasitic worms.
13 s, ES-62, an immunomodulator secreted by the parasitic worm Acanthocheilonema viteae, can prevent pat
14 provide a new model to better understand how parasitic worms activate, co-opt, or evade the vertebrat
15 acteristic feature of the immune response to parasitic worms and allergens.
16  characteristic features of immunity against parasitic worms and allergens.
17 tors of type 2 immune responses triggered by parasitic worms and allergens.
18                Brugia malayi are thread-like parasitic worms and one of the etiological agents of Lym
19 A to control human morbidity attributable to parasitic worms and progress toward elimination.
20                                              Parasitic worms and tuberculosis (TB) are involved in on
21 osure to environmental allergens, infectious parasitic worms, and microbes.
22             Traditional screens that rely on parasitic worms are costly and labour intensive and targ
23                             Larval stages of parasitic worms are killed in vitro by eosinophils in th
24 is a characteristic of endoparasites such as parasitic worms as well as of ectoparasites such as mosq
25                                          The parasitic worm Ascaris suum contains the opiate alkaloid
26 h taken together, stand to keep the study of parasitic worms at the forefront of immunology for years
27                                discover that parasitic worms, but not commensal protists, stimulate t
28    Learning more about the cells that enable parasitic worms called schistosomes to reproduce inside
29                 The Th2 response provoked by parasitic worms can modulate immune reactions to unrelat
30                                              Parasitic worms express host-like glycans to attenuate t
31                                          The parasitic worm Fasciola hepatica induces strong Th2 and
32  the host immune response that distinguishes parasitic worms from other pathogens, yet a discrete fun
33  Finally, we have developed a new portal for parasitic worm genomes.
34 ses that are induced by infection with these parasitic worms has increased markedly.
35                           PURPOSE OF REVIEW: Parasitic worms have evolved strategies to manipulate th
36                                              Parasitic worms (helminths) are common in tropical clima
37 eficial therapeutic effects of infections by parasitic worms (helminths) in some inflammatory disorde
38 tion is a defining feature of infection with parasitic worms (helminths), as well as being responsibl
39                  Loss of routine exposure to parasitic worms (helminths), due to modern highly hygien
40 ases may result from our loss of exposure to parasitic worms (helminths).
41 s critical for type 2 immune defense against parasitic worms (helminths).
42                                 Allergic and parasitic worm immunity is characterized by infiltration
43 tral to the establishment and maintenance of parasitic worms in their hosts.
44 species, we studied the numbers and types of parasitic worms in two species of house mice (Mus muscul
45                                              Parasitic worms infect billions of people worldwide.
46                                              Parasitic worm infection, allergy and asthma involve inc
47 Selective evolutionary mechanisms, driven by parasitic worm infection, may underlie the genetic contr
48 a defining feature of the immune response to parasitic worm infection.
49 9 in host-protective type 2 immunity against parasitic worm infection.
50  components of the innate immune response to parasitic worm infections and have also been implicated
51 responses elicited by allergic reactions and parasitic worm infections are characterised by the induc
52 r to be protective features in resistance to parasitic worm infections prevalent in many developing c
53            Within the context of immunity to parasitic worm infections, eosinophils are prominent yet
54 e IL-4, which underpins allergic disease and parasitic worm infections, than macrophages from lung ti
55  in developing countries it protects against parasitic worm infections.
56 t the natural immunogenic targets seen after parasitic worm infections.
57                                        These parasitic-worm infections are typically treated with alb
58                     The transmission of many parasitic worms involves aggregated movement between hos
59 the microfilarial sheath protein shp2 of the parasitic worm Litomosoides carinii.
60  research area to form an opinion on whether parasitic worms may be exploited to generate novel thera
61                      ShK-related peptides in parasitic worms may contribute to the potential benefici
62         In spite of increasing evidence that parasitic worms may protect humans from developing aller
63                                              Parasitic worms modulate host immune responses in ways t
64 l to mounting an appropriate defense against parasitic worms, noxious substances, toxins, venoms, and
65 and antimicrobial properties, but effects on parasitic worms of the intestine have not been investiga
66  ocular onchocerciasis in which Ags from the parasitic worm Onchocerca volvulus are injected into the
67               Developing in vitro assays for parasitic worms presents several challenges.
68 mpounds that target DCs can be designed from parasitic worm products and demonstrate the potential fo
69  studies of microbial communities inhabiting parasitic worms remain scarce.
70 ia, a bacterial microbiota, is essential for parasitic worms responsible for lymphatic filariasis and
71  three species of whipworm, soil-transmitted parasitic worms responsible for trichuriasis.
72  that can provide N-glycans expressed by the parasitic worm S. mansoni having unique epitopes at each
73 the major secretory product of eggs from the parasitic worm S. mansoni, efficiently triggers basophil
74                             A marker for the parasitic worm Schistosoma was used in this study.
75              Among many survival strategies, parasitic worms secrete molecules that modulate host imm
76                 Immune responses elicited by parasitic worms share many features with those of chroni
77 hogenic fungal infections and potent against parasitic worms such as Brugia, which causes lymphatic f
78  population (SmLE-PZQ-R) in which 35% of the parasitic worms survive high-dose PZQ (73 micrograms per
79 nbrockia plumatellae is an active, muscular, parasitic worm that belongs to the phylum Myxozoa, a gro
80                          Filarial nematodes, parasitic worms that cause elephantiasis, chronic skin l
81    Such a mechanism may be deployed by other parasitic worms that depend upon chronic infection for s
82 ugs, diagnostics, and vaccines for targeting parasitic worms that infect humans.
83                                           Is parasitic worm therapy for allergy incongruous medicine,
84 he potential beneficial effects of probiotic parasitic worm therapy in human autoimmune diseases.
85 uclear receptors have begun to be studied in parasitic worms, where they are widely distributed and p
86 obal health problem caused by blood-dwelling parasitic worms, which is currently tackled primarily by